Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results
2013 ◽
Vol 128
(3)
◽
pp. 518-523
◽
2014 ◽
Vol 90
(4)
◽
pp. 778-785
◽
2020 ◽
Vol 108
(3)
◽
pp. e453
2011 ◽
Vol 205
(2)
◽
pp. 148.e1-148.e6
◽
2013 ◽
Vol 85
(3)
◽
pp. 714-720
◽
2007 ◽
Vol 131
(2)
◽
pp. 236-238
◽